Cargando…
TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination
BACKGROUND: Chemoresistance is a critical risk problem for breast cancer treatment. However, mechanisms by which chemoresistance arises remains to be elucidated. The expression of T-box transcription factor 15 (TBX-15) was found downregulated in some cancer tissues. However, role and mechanism of TB...
Autores principales: | Jiang, Cheng-Fei, Xie, Yun-Xia, Qian, Ying-Chen, Wang, Min, Liu, Ling-Zhi, Shu, Yong-Qian, Bai, Xiao-Ming, Jiang, Bing-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522147/ https://www.ncbi.nlm.nih.gov/pubmed/34663310 http://dx.doi.org/10.1186/s12935-021-02235-w |
Ejemplares similares
-
IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer
por: Wen, Yi-Yang, et al.
Publicado: (2017) -
Identification of TBX2 and TBX3 variants in patients with conotruncal heart defects by target sequencing
por: Xie, Huilin, et al.
Publicado: (2018) -
KIF15 is involved in development and progression of Burkitt lymphoma
por: Wang, Zhao, et al.
Publicado: (2021) -
Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells
por: Lin, Yanzhu, et al.
Publicado: (2019) -
rs61991156 in miR-379 is associated with low capability of glycolysis of gastric cancer by enhanced regulation of PKM2
por: Cao, Na, et al.
Publicado: (2018)